Patient Empowerment Project (PEP) Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patient Empowerment Program (PEP).
- Who it may be relevant to
- Registry conditions: Infertility, Mental Health. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Efficacy of an Infertility Patient Empowerment Project (PEP), a Pilot Study
Overview
The Patient Empowerment Project (PEP) will be integrated into the intake process at a fertility clinic to prepare clinical staff for any patient sensitivities or preferences and provide extra support if needed. The study will evaluate if the PEP increases patient retention and patient satisfaction scores.
Interventions
- Behavioral Patient Empowerment Program (PEP)
The clinic staff will receive PEP training from a licensed psychologist (the PI). PEP will be implemented, starting after training is complete. The PEP Introduction and the PEP Questionnaire will be included in the New Patient Packet. The patient will complete the PEP questionnaire as they complete their new patient intake forms. Clinic staff will tailor their approach to the patient based on the patient's responses to the questionnaire.
Primary outcome measures
- Patient Satisfaction [Time frame: New Patient consultation to 6 months later]
- Patient Retention Rate [Time frame: New patient consultation to 6 months later]
Eligibility criteria
Patients seeking fertility treatment at participating clinics
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 2 centers
- The Reproductive Medicine Group — Tampa
- Aspire Fertility Dallas — Dallas
Identifiers
NCT: NCT07725458 · IRI-PEP-2026-003